Izotropic Corporation (CSE: IZO)

Izotropic Income Statement

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2024	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cost of Revenue	-	-	-	-	0.28	0.06
Gross Profit	-	-	-	-	-0.28	-0.06
Selling, General & Admin	0.69	0.69	1.66	1.81	3.75	1.01
Research & Development	0.8	0.8	2.39	3.46	0.79	-
Operating Expenses	1.63	1.63	5.24	6.35	4.55	1.01
Operating Income	-1.63	-1.63	-5.24	-6.35	-4.82	-1.08
Interest Expense	-0.25	-0.25	-0.29	-0.02	-	-
Currency Exchange Gain (Loss)	-0.04	-0.04	-0.03	-0.02	-	-
Other Non Operating Income (Expenses)	-0.07	-0.07	-0.1	-0.26	-0.15	-0.08
EBT Excluding Unusual Items	-1.99	-1.99	-5.66	-6.65	-4.98	-1.16
Other Unusual Items	0.43	0.43	-	-	-	-
Pretax Income	-1.56	-1.56	-5.66	-6.65	-4.98	-1.16
Net Income	-1.56	-1.56	-5.66	-6.65	-4.98	-1.16
Net Income to Common	-1.56	-1.56	-5.66	-6.65	-4.98	-1.16
Shares Outstanding (Basic)	54	54	50	43	35	25
Shares Outstanding (Diluted)	54	54	50	43	35	25
Shares Change (YoY)	7.53%	7.53%	16.22%	22.08%	40.72%	10.61%
EPS (Basic)	-0.03	-0.03	-0.11	-0.15	-0.14	-0.05
EPS (Diluted)	-0.03	-0.03	-0.11	-0.15	-0.14	-0.05
Free Cash Flow	-0.59	-0.59	-3.3	-4.79	-3.08	-0.99
Free Cash Flow Per Share	-0.01	-0.01	-0.07	-0.11	-0.09	-0.04
EBITDA	-1.6	-1.6	-5.22	-6.34	-4.82	-1.07
D&A For EBITDA	0.02	0.02	0.02	0.01	0	0
EBIT	-1.63	-1.63	-5.24	-6.35	-4.82	-1.08
Advertising Expenses	-	-	-	-	0.23	-

Source: S&P Capital IQ. Standard template. Financial Sources.